Table 3.
Approach 1 | Approach 2 | Approach 3 | |||||
---|---|---|---|---|---|---|---|
CEexperimental | 10 | 20 | 40 | 10 | 20 | 40 | Σa |
CEin silico | 10 | 20 | 40 | Σ | Σ | Σ | Σ |
No. of compounds scored | 363 | 368 | 360 | 363 | 368 | 360 | 377 |
Number of true positives | |||||||
Top hit | 159 | 178 | 123 | 171 | 180 | 128 | 188 |
Within top 5 | 239 | 250 | 194 | 243 | 252 | 194 | 268 |
Within top 20 | 284 | 291 | 232 | 295 | 292 | 232 | 321 |
Percentage of true positives | |||||||
Top hit | 44% | 48% | 34% | 47% | 49% | 36% | 50% |
Within top 5 | 66% | 68% | 54% | 67% | 68% | 54% | 71% |
Within top 20 | 78% | 79% | 64% | 81% | 79% | 64% | 85% |
Average percentile for true positives | 82nd | 83rd | 76th | 83rd | 84th | 77th | 84th |
Average quotient for true positives | 0.77 | 0.73 | 0.57 | 0.77 | 0.75 | 0.59 | 0.79 |
aSum of three CEs